Author: healthprofessionalradio

Guest: Judith K. Wolf, MD

Presenter: Neal Howard

Guest Bio: Judith K. Wolf, MD, joined Provista as the Chief Medical Officer in June 2016 from Vermillion, Inc. where she served as the Chief Medical Officer. Dr. Wolf is a Gynecologic Oncologist. Dr. Wolf serves as a board member of the Society for Women’s Health Research and co-founded the Sprint for Life 5K fundraiser, which supports the ovarian cancer research program at MD Anderson.

Segment overview: Dr. Judith K. Wolf discusses a new study that demonstrates that a blood test used with imaging can improve breast cancer detection and substantially reduce the use of potentially avoidable biopsies for women under 50.

Guest: Dr. AJ Alva

Presenter: Neal Howard

Guest Bio: Ajjai Alva, MBBS, is a medical oncologist at the University of Michigan specializing in genitourinary cancers of the bladder, kidney and prostate. His focus is on developing and optimizing precision oncologic care with use of next generation tumor sequencing and circulating cell-free tumor DNA assays to yield biomarkers to select and monitor patients on personalized therapies.  He was trained at the University of Maryland in Cell Biology and Molecular Genetics before completing a hematology/oncology fellowship at the University of Michigan.

Segment overview: Segment 3:  Dr. Ajjai Shivaram Alva, MBBS, from the Michigan Medicine Urology Oncology Clinic, discusses the crucial need for increased awareness and dialogue among patients, caregivers, and HCPs.

Guest: Dr. AJ Alva  

Presenter: Neal Howard

Guest Bio: Ajjai Alva, MBBS, is a medical oncologist at the University of Michigan specializing in genitourinary cancers of the bladder, kidney and prostate. His focus is on developing and optimizing precision oncologic care with use of next generation tumor sequencing and circulating cell-free tumor DNA assays to yield biomarkers to select and monitor patients on personalized therapies.  He was trained at the University of Maryland in Cell Biology and Molecular Genetics before completing a hematology/oncology fellowship at the University of Michigan.

Segment overview: Segment 2:  Dr. Ajjai Shivaram Alva, MBBS, from the Michigan Medicine Urology Oncology Clinic, talks about the incidence of bladder cancer. the landscape, and how patients face unique challenges as a result of their disease.

Guest: Dr. AJ Alva  

Presenter: Neal Howard

Guest Bio: Ajjai Alva, MBBS, is a medical oncologist at the University of Michigan specializing in genitourinary cancers of the bladder, kidney and prostate. His focus is on developing and optimizing precision oncologic care with use of next generation tumor sequencing and circulating cell-free tumor DNA assays to yield biomarkers to select and monitor patients on personalized therapies.  He was trained at the University of Maryland in Cell Biology and Molecular Genetics before completing a hematology/oncology fellowship at the University of Michigan.

Segment overview: Segment 1:  Dr. Ajjai Shivaram Alva, MBBS, from the Michigan Medicine Urology Oncology Clinic, discusses the recent FDA approval of a treatment that uses the body’s own immune system against bladder cancer.

Guest: Peter Crock

Presenter: Wayne Bucklar

Guest Bio: Peter is an experienced public company senior manager with deep experience in marketing and technology development. In a 28-year career at Nufarm Limited (ASX: NUF), Peter held senior management roles in marketing, business development, and information technology. He led Nufarm’s new technologies division which involved the licensing and commercial development of several new agribusiness technologies. He also project managed the successful integration of newly acquired businesses and has extensive experience working with regulators in Australia and overseas. Since being appointed CEO of Cann Group, Peter has negotiated key collaborations and technology partnerships with a number of organisations, while also playing an instrumental role in helping the company secure the first regulatory licences for both medicinal cannabis research and cultivation to be issued under Australia’s new regulatory system.

Segment overview: In today’s segment, we are joined by Cann Group Limited CEO Peter Crock here to share information about their company as well as discuss the two licenses issued to the company from the Office of Drug Control (ODC). Cann Group has been issued with one medicinal cannabis permit and two cannabis research permits this year, making them the first Australian Medicinal Cannabis company to be issued with cultivation licences for both medicinal supply and research purposes under the Federal Government’s regulatory system. Their research license allows them to facilitate a research program being undertaken with CSIRO to develop unique cannabis extracts and the supply of plant material for manufacturing into medicinal cannabis products for patient use. Their recently issued medicinal cannabis license will allow them to produce Australian grown material for propagation purposes.

Guest: Drew Baird

Presenter: Henry Acosta

Guest Bio: Drew has been a qualified Personal Trainer for 5 years, he became a PT after personally experiencing the life-changing effects of fitness (it helped him overcome severe social anxiety, he was housebound at the age of 22). Drew started his online business in 2015 because he wanted to expand the number of people he could help and knew an online platform was much more accessible, especially for those who might find it tough to hit the gym due to a mental illness like anxiety or depression. Psychology around weight loss and happiness is something Drew is deeply passionate about, and he’s incredibly self-motivated to learn more. For the past 12 months he has been studying psychology, neuroscience and biology through prescribed textbooks.

Segment overview: In today’s segment, we welcome Drew from the online health and fitness platform Drew Baird Fitness here to share his thoughts about the current unrealistic portrayal of health and fitness. Currently, Drew is developing an interactive positive mindset course which will be a stand-alone product dedicated to examining the psychology behind bad habits and how to reinforce positive behaviour. He also runs live coaching calls over Zoom & Facebook Live twice a week and acts as a consistent point of support for members by personally answering any and all questions they have. Drew Baird currently employs 20 full-time staff members, has 150,000 followers on social media and has 15,000 clients across 4 countries (Australia, NZ, UK & Canada). Helping people, not just to lose weight and become physically fitter, but also to develop a more positive outlook and strengthen their mental health and coping mechanisms, is at the core of Drew’s business.

Guest: Bianca Venuti

Presenter: Henry Acosta

Guest Bio: Six months ago her amazing mum, Maria Venuti, had a major haemorrhagic stroke which resulted in significant bleeding in her brain. Even though her mum had experienced brief periods of high blood pressure in the past, it was very unexpected and such a huge shock. They were definitely not prepared for the way it has turned their lives upside down. Her recovery and rehab has been a slow process but she’s making great progress and Bianca is so proud of how far she has come. Bianca has teamed up with Priceline Pharmacy because she wants to help highlight the need for regular blood pressure checks to fight against stroke.

Segment overview: In today’s segment, we are joined by Priceline Pharmacy Mission Health Ambassador Bianca Venuti here to share information about their recently launched campaign in collaboration with the Stroke Foundation, Australia’s Biggest Blood Pressure Check. Bianca shares her mother’s stroke story to encourage others to have their blood pressure checked as this is the number one risk factor for stroke. In the previous year a total of 56,000 checks were recorded and they aim to beat that number this year. Bianca has partnered with Priceline Pharmacy, following her mother’s major haemorrhagic stroke last year, to help spread awareness on the importance of having our blood pressure checked regularly.